Inventurus Knowledge Solutions Limited (NSE:IKS)
India
· Delayed Price · Currency is INR 1,645.00
-21.60 (-1.30%)
At close: Dec 5, 2025
NSE:IKS Revenue
Inventurus Knowledge Solutions had revenue of 7.81B INR in the quarter ending September 30, 2025, with 21.52% growth. This brings the company's revenue in the last twelve months to 29.02B, up 17.51% year-over-year. In the fiscal year ending March 31, 2025, Inventurus Knowledge Solutions had annual revenue of 26.64B with 46.54% growth.
Revenue (ttm)
29.02B
Revenue Growth
+17.51%
P/S Ratio
9.73
Revenue / Employee
3.85M
Employees
7,530
Market Cap
282.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 26.64B | 8.46B | 46.54% |
| Mar 31, 2024 | 18.18B | 7.87B | 76.28% |
| Mar 31, 2023 | 10.31B | 2.68B | 35.05% |
| Mar 31, 2022 | 7.64B | 2.11B | 38.20% |
| Mar 31, 2021 | 5.53B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 549.64B |
| Divi's Laboratories | 100.29B |
| Cipla | 279.66B |
| Apollo Hospitals Enterprise | 232.65B |
| Zydus Lifesciences | 244.94B |
| Mankind Pharma | 135.46B |
| Aurobindo Pharma | 325.14B |
| Alkem Laboratories | 138.90B |